CONSTRUCTION OF EXTERNAL-CONTROL ARMS (ECA) IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM)

被引：0
|
作者：
Perkins, A. [1 ]
O'Reilly, J. [1 ]
Tunaru, F. [1 ]
Wallis, J. [1 ]
Carpenter, L. [1 ]
机构：
[1] Arcturis Data, Oxford, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
MSR105
引用
收藏
页码：S413 / S413
页数：1
相关论文
共 50 条
  • [1] Therapy of relapsed and/or refractory multiple myeloma (RRMM)
    Engelhardt, M.
    Waesch, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 14 - 14
  • [2] Selinexor for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
    Anum, Babar
    Hina, Zubair
    Mainoma, Bano
    Sana, Rafique
    Arzu, Shahid
    Maham, Babar
    Waleed, Madeeha S.
    Arslan, Inayat
    Danish, Safi
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S29 - S29
  • [3] POMALIDOMIDE IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): EXPERIENCE CENTER
    Cuesta Garcia, A.
    HAEMATOLOGICA, 2015, 100 : 104 - 104
  • [4] Pembrolizumab in Combination with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM)
    Badros, Ashraf Z.
    Hyjek, Elizabeth
    Ma, Ning
    Lesokhin, Alexander M.
    Rapoport, Aaron P.
    Kocoglu, Mehmet H.
    Lederer, Emily
    Philip, Sunita
    Lesho, Patricia
    Johnson, Ashlee
    Dell, Cameron
    Goloubeva, Olga
    Singh, Zeba
    BLOOD, 2016, 128 (22)
  • [5] Metronomic therapy for heavily pretreated relapsed/refractory multiple myeloma (RRMM).
    Papanikolaou, Xenofon
    Szymonifka, Jackie
    Mitchell, Alan
    Keller, Jason
    Heuck, Christoph Johann
    Waheed, Sarah
    Usmani, Saad Zafar
    Nair, Bijay
    Van Rhee, Frits
    Medlin, Stephen Charles
    Bailey, Clyde
    Petty, Nathan
    Hoering, Antje
    Crowley, John
    Barlogie, Bart
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Mezagitamab Induces Immunomodulatory Effect in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Abadier, Michael
    Estevam, Jose
    Berg, Deborah
    Fedyk, Eric Robert
    BLOOD, 2020, 136
  • [7] POMALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PREVIOUSLY TREATED WITH LENALIDOMIDE
    Gomez, Hernando Marta
    Gironella, Merce
    Abella, Eugenia
    Cabezudo, Elena
    Motllo, Cristina
    Garcia, Antoni
    Sarra, Josep
    Mostacedo, Silvia
    Granell, Miquel
    Rosinol, Laura
    HAEMATOLOGICA, 2020, 105 : 13 - 14
  • [8] PATIENT PREFERENCES REGARDING TREATMENT OPTIONS FOR RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM)
    Bauer, S.
    Mueller, S.
    Ratsch, B.
    Pitura, S.
    Probst, L.
    van Eickels, D.
    Wilke, T.
    VALUE IN HEALTH, 2017, 20 (09) : A451 - A451
  • [9] Fractionated Dosing of CLR 131 in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
    Ailawadhi, Sikander
    Stiff, Patrick J.
    Ibrahim, Emad
    Vallurupalli, Anusha
    Cull, Elizabeth H.
    Green, Damian J.
    Oliver, Kate
    Longcor, Jarrod
    BLOOD, 2019, 134
  • [10] Treatment patterns among patients with relapsed/refractory multiple myeloma (RRMM) in Taiwan
    Huang, Jeffrey Shang-Yi
    Wang, Ming-Chung
    Yeh, Su-Peng
    Chen, Tsai-Yun
    Teng, Chieh-Lin Jerry
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S188 - S189
12345